Prostate Cancer Trial, Recruiting (NCT04625556)

Prostate Cancer Trial, Recruiting NCT04625556 Sponsor: Yonsei University Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04625556 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with a urological cancer, specifically prostate cancer, kidney cancer, bladder cancer, or ureter cancer
People who have had surgery for one of these urological cancers at Severance Hospital, Sinchon, between October 2020 and October 2030
People who agree to allow their personal health information to be used for this study
People who agree to take part in this study

Who may not be able to join:

People who do not agree to take part in this study
People who may be in a situation where they could feel pressured into agreeing, or who may not be fully able to make their own decision about whether to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Won Sik Ham, Severance Hospital

Phone: 82-02-2228-2310

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04625556

Sponsor: Yonsei University

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 82-02-2228-2310

More information: https://clinicaltrials.gov/study/NCT04625556

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with a urological cancer, specifically prostate cancer, kidney cancer, bladder cancer, or ureter cancer
People who have had surgery for one of these urological cancers at Severance Hospital, Sinchon, between October 2020 and October 2030
People who agree to allow their personal health information to be used for this study
People who agree to take part in this study

Who may not be able to join:

People who do not agree to take part in this study
People who may be in a situation where they could feel pressured into agreeing, or who may not be fully able to make their own decision about whether to participate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Yonsei University

Registry

ClinicalTrials.gov

Start date

19 December 2022

Est. completion

1 October 2030

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Correlation between tissue bacteria composition and prevalence of urological malignancies; Correlation between plasma bacteria composition and prevalence of urological malignancies; Correlation between stool bacteria composition and prevalence of urological malignancies; Correlation between urine bacteria composition and prevalence of urological malignancies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov